Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Gold

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Molecular Evolution|October 21, 2015
SELEX: How It Happened and Where It will GoLarry Gold
RNA Biology|April 17, 2014
Carl Woese in Schenectady: the forgotten yearsLarry Gold
Nature Biotechnology|June 29, 2002
RNA as the catalyst for drug screeningLarry Gold
Current Opinion in Biotechnology|September 27, 2002
Dimensionality is the issue: use of photoaptamers in protein microarraysHelen Petach, Larry Gold
Personalized Medicine|May 16, 2018
Taking measure of personalized medicine: the proteomeFintan Steele, Larry Gold
Journal of Personalized Medicine|January 7, 2015
DTC-and-Me: Patient, Provider, Proteins and RegulatorsFintan R Steele, Larry Gold
Nature Biotechnology|July 12, 2012
The sweet allure of XNAFintan R Steele, Larry Gold
Proteomics|January 8, 2014
Beyond antibodies: new affinity reagents to unlock the proteomeBridget Lollo, Fintan Steele, Larry Gold
Chemistry & Biology|December 25, 2002
One, two, infinity: genomes filled with aptamersLarry Gold, Ed Brody, Joe Heilig, et al.
Current Opinion in Chemical Biology|February 16, 2008
Proteomics and diagnostics: Let's Get Specific, againDom Zichi, Bruce Eaton, Britta Singer, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Molecular Evolution|October 21, 2015
SELEX: How It Happened and Where It will GoLarry Gold
RNA Biology|April 17, 2014
Carl Woese in Schenectady: the forgotten yearsLarry Gold
Nature Biotechnology|June 29, 2002
RNA as the catalyst for drug screeningLarry Gold
Current Opinion in Biotechnology|September 27, 2002
Dimensionality is the issue: use of photoaptamers in protein microarraysHelen Petach, Larry Gold
Personalized Medicine|May 16, 2018
Taking measure of personalized medicine: the proteomeFintan Steele, Larry Gold
Journal of Personalized Medicine|January 7, 2015
DTC-and-Me: Patient, Provider, Proteins and RegulatorsFintan R Steele, Larry Gold
Nature Biotechnology|July 12, 2012
The sweet allure of XNAFintan R Steele, Larry Gold
Proteomics|January 8, 2014
Beyond antibodies: new affinity reagents to unlock the proteomeBridget Lollo, Fintan Steele, Larry Gold
Chemistry & Biology|December 25, 2002
One, two, infinity: genomes filled with aptamersLarry Gold, Ed Brody, Joe Heilig, et al.
Current Opinion in Chemical Biology|February 16, 2008
Proteomics and diagnostics: Let's Get Specific, againDom Zichi, Bruce Eaton, Britta Singer, et al.
Pageof 4